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8S Abstracts May Supplement 2013median baseline hsCRP was 6.2 mg/L (IQR, 2.4-10). Most
vein grafts (68%) were single-segment great saphenous vein
and 63% were femoral-popliteal bypasses. Mean baseline
brachial artery FMD was 7.6 6 4.5%. Mean graft lumen
diameter increased from 4.3 6 0.8 mm at surgery to 4.7 6
0.8 mm at 3 months. There was a signiﬁcant correlation
between initial lumen diameter and 0-3 months remodeling
(r¼.48;P¼ .02).No correlationwas seenbetween brachial
FMD and vein graft FMD. Mature ($12 months) grafts had
signiﬁcantly higher FMD than early (3 months) grafts (4.56
2.7% vs 0.6 6 1.9%; P < .0005) and there was a signiﬁcant
positive correlation between early and late graft FMD (r ¼
.64; P ¼ .01). We did not observe a signiﬁcant correlation
between early graft remodeling and either brachial or vein
graft FMD.
Conclusions: LEVBG patients have endothelial
dysfunction demonstrated by impaired brachial artery
FMD. Veins grafts exhibit recovery of endothelial function
over the ﬁrst year of implantation. However, early
geometric remodeling appears asynchronous from physio-
logic endothelial recovery in the aterialized vein.
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The Society for Vascular Surgery’s Objective
Performance Goals for Critical Limb Ischemia Are
Attainable With Contemporary Endovascular Therapy
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Darren B. Schneider. Vascular Surgery, Weill Cornell
Medical College / New York-Presbyterian, New York, NY
Objectives: The Society for Vascular Surgery’s Objec-
tive Performance Goals (SVS OPGs) for critical limb
ischemia (CLI) are derived from bypass surgery outcomes
in a pooled cohort from 3 randomized trials. We examine
the effectiveness of endovascular therapy (ET) for CLI in
using OPG efﬁcacy benchmarks.
Methods: CLI patients undergoing ET (2006-2012),
were identiﬁed in a prospectively maintained database.
Unadjusted outcomes were used for comparisons to theTable. One year results with endovascular therapy compared
Outcome metric
Overall
OPG (n ¼ 838) Endo (n ¼
Major adverse limb event or post-op death (MALE +
POD)
71% 73 6 3%
Amputation-free survival (AFS) 71% 66 6 3%
Reintervention, amputation, or stenosis (RAS) 39% 43 6 4%
Reintervention or amputation (RAO) 55% 60 6 4%
Limb salvage 84% 85 6 3%
Survival 80% 74 6 3%
Rates reported as freedom from adverse events.overall OPG cohort, as well as between anatomic and clin-
ical high-risk subgroups. ET-speciﬁc regression models for
each OPG end point identiﬁed risk factors for poor
outcome.
Results: 283 CLI patients underwent ET for tissue
loss (77%) or rest pain. Compared to the OPG cohort
(n ¼ 838), patients undergoing ET were more likely to
be >80 years old (32% vs 19%; P < .0001), female (51%
vs 34%; P < .0001), have end stage renal disease (ESRD)
(15% vs 0%; P < .0001), or anatomic high-risk features
(73% vs 60%; P ¼ .002). The mean reintervention rate after
ET was 0.67 per limb-year. The overall effectiveness of ET,
with subgroup analysis, is summarized in the Table.
Conclusions: Although survival-based benchmarks
may be difﬁcult to achieve in “real world” practice that
includes poor surgical candidates and those with ESRD,
most SVS OPGs are attainable with contemporary endo-
vascular therapy. These ﬁndings not only support the role
of ET in the management of CLI, but underscore the
utility of SVS OPGs for comparative effectiveness and
outcomes research.
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Intervention, Failure Mechanism, Patency, Wound
Complications, and Limb Salvage in Open Versus
Endoscopic Greater Saphenous Vein Harvest for
Lower Extremity Revascularization
Vincent J. Santo, Phong Dargon, Gregory J. Landry,
Timothy K. Liem, Erica L. Mitchell, Amir F. Azarbal,
Gregory L. Moneta. General Surgery, Oregon Health &
Science University, Portland, Ore
Objectives: Determine intervention rates, failure
mechanisms, patency, wound complications and limb
salvage after lower extremity revascularization using open
(OVH) vs endoscopic vein harvest (EVH).
Methods: Single institution review of consecutive
patients between 2005 and 2012, who underwent infrain-
guinal bypass with reversed greater saphenous vein (GSV).to suggested OPGs
Clinical high risk Anatomic high risk
283) OPG (n ¼ 136) Endo (n ¼ 56) OPG (n ¼ 505) Endo (n ¼ 206)
61% 69 6 8% 67% 73 6 5%
53% 60 6 7% 68% 66 6 4%
29% 47 6 8% 36% 56 6 5%
54% 53 6 8% 51% 59 6 5%
80% 82 6 7% 81% 83 6 4%
63% 69 6 7% 80% 77 6 4%
